BCL2 and gastric cancer: Positive Bcl-2 expression was significantly more frequent in patients with more advanced gastric cancer (T3, T4) than in those with less advanced tumors (T1, T2), (37/58; 63.8% versus 12/30; 40%, P < 0.05).